Helping the Community and the World One Patient at a Time
A Multicenter, Longitudinal, Open-Label, Single -Arm Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated with Ozanimod (RPC-1063)
Biomarker Analysis for GBA Associated Parkinson's Disease
A Clinical study of Patients with Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy.
Exploring the safety and tolerability of conversion from oral or injectable disease modifying therapies to dose titrated Oral Siponimod in patients with advancing forms of relapsing multiple sclerosis
The study will evaluate the efficacy and safety of evobrutinib administered orally twice daily versus Interferon-beta-1a (Avonex®), once a week intramuscularly in participants with Relapsing Multiple Sclerosis (RMS).
Multicenter, Randomized, Double-blind, Parallel-group, add-on, Superiority Study to compare the efficacy and safety of Ponesimod to placebo in subjects with active Relapsing Multiple Sclerosis who are treated with Dimethyl Fumarate (Tecfidera)
A phase IIIb multi-center, randomized double-blind, placebo controlled study to evaluate the efficacy and safety of Ocrelizumab in adults with primary progressive multiple sclerosis.
Adamas Pharmaceuticals, Inc.
A 2-Arm, Multicenter, Double-Blind, Placebo-Controlled, Randomized Study to Assess the Efficacy and Safety of ADS-5102 Amantadine Extended Release Capsules in Multiple Sclerosis Patients with Walking Impairment.
A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ADX48621 in the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease
Copyright © 2019 Geodyssey Research LLC - All Rights Reserved.